95 related articles for article (PubMed ID: 29589748)
1. Biochemical and Structural Studies of the Interaction between ARAP1 and CIN85.
Li Q; Yang W; Wang Y; Liu W
Biochemistry; 2018 Apr; 57(14):2132-2139. PubMed ID: 29589748
[TBL] [Abstract][Full Text] [Related]
2. ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking.
Yoon HY; Kales SC; Luo R; Lipkowitz S; Randazzo PA
Biol Cell; 2011 Apr; 103(4):171-84. PubMed ID: 21275903
[TBL] [Abstract][Full Text] [Related]
3. Interactions between the three CIN85 SH3 domains and ubiquitin: implications for CIN85 ubiquitination.
Bezsonova I; Bruce MC; Wiesner S; Lin H; Rotin D; Forman-Kay JD
Biochemistry; 2008 Aug; 47(34):8937-49. PubMed ID: 18680311
[TBL] [Abstract][Full Text] [Related]
4. Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.
Ahmad G; Mohapatra BC; Schulte NA; Nadeau SA; Luan H; Zutshi N; Tom E; Ortega-Cava C; Tu C; Sanada M; Ogawa S; Toews ML; Band V; Band H
Int J Biochem Cell Biol; 2014 Dec; 57():123-34. PubMed ID: 25449262
[TBL] [Abstract][Full Text] [Related]
5. Multimeric and differential binding of CIN85/CD2AP with two atypical proline-rich sequences from CD2 and Cbl-b*.
Ceregido MA; Garcia-Pino A; Ortega-Roldan JL; Casares S; López Mayorga O; Bravo J; van Nuland NA; Azuaga AI
FEBS J; 2013 Jul; 280(14):3399-415. PubMed ID: 23663663
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide.
Sato S; Zhao Y; Imai M; Simister PC; Feller SM; Trackman PC; Kirsch KH; Sonenshein GE
PLoS One; 2013; 8(10):e77288. PubMed ID: 24167568
[TBL] [Abstract][Full Text] [Related]
7. CIN85 interacting proteins in B cells-specific role for SHIP-1.
Büchse T; Horras N; Lenfert E; Krystal G; Körbel S; Schümann M; Krause E; Mikkat S; Tiedge M
Mol Cell Proteomics; 2011 Oct; 10(10):M110.006239. PubMed ID: 21725061
[TBL] [Abstract][Full Text] [Related]
8. SH3KBP1-binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c-Cbl-CIN85 complex.
Feng L; Wang JT; Jin H; Qian K; Geng JG
Cell Biochem Funct; 2011 Oct; 29(7):589-96. PubMed ID: 21830225
[TBL] [Abstract][Full Text] [Related]
9. Novel insights into the mechanisms of CIN85 SH3 domains binding to Cbl proteins: solution-based investigations and in vivo implications.
Ababou A; Pfuhl M; Ladbury JE
J Mol Biol; 2009 Apr; 387(5):1120-36. PubMed ID: 19268472
[TBL] [Abstract][Full Text] [Related]
10. The basic amino acids in the coiled-coil domain of CIN85 regulate its interaction with c-Cbl and phosphatidic acid during epidermal growth factor receptor (EGFR) endocytosis.
Zheng X; Zhang J; Liao K
BMC Biochem; 2014 Jul; 15():13. PubMed ID: 25005938
[TBL] [Abstract][Full Text] [Related]
11. The binding stoichiometry of CIN85 SH3 domain A and cbl-b.
Ababou A; Pfuhl M; Ladbury JE
Nat Struct Mol Biol; 2008 Sep; 15(9):890-1; author reply 891-2. PubMed ID: 18769462
[No Abstract] [Full Text] [Related]
12. Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptors.
Kowanetz K; Szymkiewicz I; Haglund K; Kowanetz M; Husnjak K; Taylor JD; Soubeyran P; Engstrom U; Ladbury JE; Dikic I
J Biol Chem; 2003 Oct; 278(41):39735-46. PubMed ID: 12874286
[TBL] [Abstract][Full Text] [Related]
13. Atypical recognition consensus of CIN85/SETA/Ruk SH3 domains revealed by target-assisted iterative screening.
Kurakin AV; Wu S; Bredesen DE
J Biol Chem; 2003 Sep; 278(36):34102-9. PubMed ID: 12829691
[TBL] [Abstract][Full Text] [Related]
14. Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex.
Schmidt MHH; Hoeller D; Yu J; Furnari FB; Cavenee WK; Dikic I; Bögler O
Mol Cell Biol; 2004 Oct; 24(20):8981-93. PubMed ID: 15456872
[TBL] [Abstract][Full Text] [Related]
15. Cbl promotes clustering of endocytic adaptor proteins.
Jozic D; Cárdenes N; Deribe YL; Moncalián G; Hoeller D; Groemping Y; Dikic I; Rittinger K; Bravo J
Nat Struct Mol Biol; 2005 Nov; 12(11):972-9. PubMed ID: 16228008
[TBL] [Abstract][Full Text] [Related]
16. Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.
Haglund K; Schmidt MHH; Wong ES; Guy GR; Dikic I
EMBO Rep; 2005 Jul; 6(7):635-41. PubMed ID: 15962011
[TBL] [Abstract][Full Text] [Related]
17. Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking.
Nonis D; Schmidt MHH; van de Loo S; Eich F; Dikic I; Nowock J; Auburger G
Cell Signal; 2008 Oct; 20(10):1725-39. PubMed ID: 18602463
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl.
Take H; Watanabe S; Takeda K; Yu ZX; Iwata N; Kajigaya S
Biochem Biophys Res Commun; 2000 Feb; 268(2):321-8. PubMed ID: 10679202
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of human tristetraprolin in response to its interaction with the Cbl interacting protein CIN85.
Kedar VP; Darby MK; Williams JG; Blackshear PJ
PLoS One; 2010 Mar; 5(3):e9588. PubMed ID: 20221403
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus 1 infected cell protein 0 forms a complex with CIN85 and Cbl and mediates the degradation of EGF receptor from cell surfaces.
Liang Y; Kurakin A; Roizman B
Proc Natl Acad Sci U S A; 2005 Apr; 102(16):5838-43. PubMed ID: 15824310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]